Lotte Haverman

5.2k total citations · 1 hit paper
131 papers, 2.9k citations indexed

About

Lotte Haverman is a scholar working on Pediatrics, Perinatology and Child Health, Speech and Hearing and Clinical Psychology. According to data from OpenAlex, Lotte Haverman has authored 131 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Pediatrics, Perinatology and Child Health, 40 papers in Speech and Hearing and 39 papers in Clinical Psychology. Recurrent topics in Lotte Haverman's work include Childhood Cancer Survivors' Quality of Life (53 papers), Adolescent and Pediatric Healthcare (40 papers) and Family and Disability Support Research (28 papers). Lotte Haverman is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (53 papers), Adolescent and Pediatric Healthcare (40 papers) and Family and Disability Support Research (28 papers). Lotte Haverman collaborates with scholars based in Netherlands, United States and Canada. Lotte Haverman's co-authors include Martha A. Grootenhuis, Hedy A. van Oers, Heleen Maurice‐Stam, Perrine F. Limperg, Sasja A. Schepers, Maria Santana, Lorynn Teela, Caroline B. Terwee, Marion A. J. van Rossum and Maud M. van Muilekom and has published in prestigious journals such as Blood, PEDIATRICS and Cancer.

In The Last Decade

Lotte Haverman

118 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The impact of lockdown during the COVID-19 pandemic on mental and social health of children and adolescents

2021 147 citations Michiel A. J. Luijten, Maud M. van Muilekom et al. Quality of Life Research profile →

Peers

Countries citing papers authored by Lotte Haverman

Since Specialization

Citations

This map shows the geographic impact of Lotte Haverman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lotte Haverman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lotte Haverman more than expected).

Fields of papers citing papers by Lotte Haverman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lotte Haverman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lotte Haverman. The network helps show where Lotte Haverman may publish in the future.

Co-authorship network of co-authors of Lotte Haverman

This figure shows the co-authorship network connecting the top 25 collaborators of Lotte Haverman. A scholar is included among the top collaborators of Lotte Haverman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lotte Haverman. Lotte Haverman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Understanding the impact of tuberous sclerosis complex: development and validation of the TSC-PROM 2025 ·UNC Libraries ·Lotte Haverman, Tanjala Gipson, Leontine W. ten Hoopen, (unknown), Marie‐Claire Y. de Wit, Michiel A. J. Luijten, Anna Jansen, André B. Rietman, Peter Janssens, Agnies M. van Eeghen, (unknown), Petrus J. de Vries, (unknown), Jamie K. Capal	1
2	Psychometric properties and reference values of the Patient-Reported Outcomes Measurement Information System (PROMIS®) pediatric item banks Mobility, Upper Extremity, and Pain Interference in the Dutch population 2025 ·Journal of Clinical Epidemiology ·(unknown), Marjolijn Ketelaar, (unknown), Caroline B. Terwee, Manon Bloemen, Eugène Rameckers, Raoul Engelbert, Hedy A. van Oers, Lotte Haverman, Michiel A. J. Luijten	0
3	Definitions and operationalizations of pediatric chronic patients: a scoping review 2025 ·European Journal of Pediatrics ·(unknown), (unknown), (unknown), (unknown), Faridi S. van Etten‐Jamaludin, Lotte Haverman, Willem B. de Vries, Anne Eskes, Jolanda Maaskant	0
4	Patient reported outcomes used in clinical trials and core outcome sets for individuals with genetic intellectual disability: a scoping review 2025 ·Journal of Neurodevelopmental Disorders ·(unknown), Maud M. van Muilekom, Clara D.M. van Karnebeek, Joost G. Daams, Lotte Haverman, Agnies M. van Eeghen	1
5	Changes in the quality of life of adults with sickle cell disease following allogeneic stem cell transplantation: A mixed‐methods, prospective cohort study 2025 ·HemaSphere ·(unknown), (unknown), Annemarie Braamse, Maud M. van Muilekom, (unknown), (unknown), Charlotte F.J. Van Tuijn, Michael R. DeBaun, Bart J. Biemond, Lotte Haverman, Erfan Nur	0
6	The Amsterdam PROM Implementation Strategy: Policy and Pathway 2024 ·NEJM Catalyst ·(unknown), Maud M. van Muilekom, (unknown), Michiel A. J. Luijten, (unknown), (unknown), (unknown), Caroline B. Terwee, Piet M. ter Wee, Hedy A. van Oers, Lotte Haverman	8
7	Navigating the outcome maze: a scoping review of outcomes and instruments in clinical trials in genetic neurodevelopmental disorders and intellectual disability 2024 ·PubMed ·(unknown), (unknown), (unknown), (unknown), (unknown), Marion M. Brands, Lotte Haverman, Caroline B. Terwee, Carlo Schuengel, Joost G. Daams, David Hessl, Frits A. Wijburg, Erik Boot, Agnies M. van Eeghen	5
8	Understanding the impact of tuberous sclerosis complex: development and validation of the TSC-PROM 2023 ·BMC Medicine ·(unknown), Michiel A. J. Luijten, Lotte Haverman, (unknown), Peter Janssens, André B. Rietman, Leontine W. ten Hoopen, (unknown), Marie‐Claire Y. de Wit, Anna Jansen, Tanjala Gipson, Jamie K. Capal, Petrus J. de Vries, Agnies M. van Eeghen	5
9	Optimising HIV care using information obtained from PROMs: protocol for an observational study 2023 ·BMJ Open ·(unknown), Pythia T. Nieuwkerk, (unknown), Jeannine F. Nellen, Annouschka M. Weijsenfeld, Kim Sigaloff, Laura Laan, (unknown), (unknown), Lotte Haverman, Suzanne E. Geerlings, Marc van der Valk	1
10	Psychometrics of the patient-reported outcomes measurement information system measures in hemophilia: the applicability of the pediatric item banks 2023 ·Research and Practice in Thrombosis and Haemostasis ·Lorynn Teela, Michiel A. J. Luijten, (unknown), (unknown), (unknown), Samantha C. Gouw, Karin Fijnvandraat, Kathelijn Fischer, Marjon H. Cnossen, (unknown), (unknown), (unknown), (unknown), Marjolein Peters, Lotte Haverman	3
11	Follow‐up of infants with colic into childhood: Do they develop behavioural problems? 2022 ·Journal of Paediatrics and Child Health ·Judith Zeevenhooven, (unknown), Renske Schappin, Arine M. Vlieger, (unknown), Lotte Haverman, B.E. van Sleuwen, Monique P. L’Hoir, Marc A. Benninga	10
12	Late Effects in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation for Nonmalignant Diseases: Proxy- and Patient-Reported Outcomes 2022 ·Transplantation and Cellular Therapy ·(unknown), Lotte Haverman, (unknown), Marloes Louwerens, Michiel A. J. Luijten, Anne M. Stiggelbout, Arjan C. Lankester, Anne P.J. de Pagter	3
13	Prevalence and determinants of persistent symptoms after infection with SARS-CoV-2: protocol for an observational cohort study (LongCOVID-study) 2022 ·BMJ Open ·(unknown), (unknown), (unknown), Albert Wong, (unknown), (unknown), Lotte Haverman, Hans Knoop, Eelco Franz, Albert Jan van Hoek, Cees C. van den Wijngaard	7
14	Preconception expanded carrier screening: a focus group study with relatives of mucopolysaccharidosis type III patients and the general population 2021 ·Journal of Community Genetics ·(unknown), (unknown), Lotte Haverman, Phillis Lakeman, Frits A. Wijburg, Lidewij Henneman	5
15	Mental and Social Health of Children and Adolescents With Pre-existing Mental or Somatic Problems During the COVID-19 Pandemic Lockdown 2021 ·Frontiers in Psychiatry ·Josjan Zijlmans, Lorynn Teela, Hanneke van Ewijk, Helen Klip, (unknown), I. Hyun Ruisch, Michiel A. J. Luijten, Maud M. van Muilekom, Kim J. Oostrom, Jan K. Buitelaar, Pieter J. Hoekstra, Ramón Lindauer, Arne Popma, Wouter Staal, Robert Vermeiren, Hedy A. van Oers, Lotte Haverman, Tinca J. C. Polderman	35
16	Using an implementation science approach to implement and evaluate patient-reported outcome measures (PROM) initiatives in routine care settings 2020 ·Quality of Life Research ·Angela M. Stover, Lotte Haverman, Hedy A. van Oers, Joanne Greenhalgh, Caroline Potter, Sara Ahmed, Elizabeth Gibbons, Kimberly Manalili, Natasha Roberts, Maria Santana, (unknown)	173
17	Matching Psychosocial Support Needs of Parents of a Child with a Chronic Illness to a Feasible Intervention 2020 ·Maternal and Child Health Journal ·(unknown), (unknown), Hedy A. van Oers, Heleen Maurice‐Stam, Lotte Haverman, Martha A. Grootenhuis, L. Scholten	9
18	Prevention of relapses with levamisole as adjuvant therapy in children with a first episode of idiopathic nephrotic syndrome: study protocol for a double blind, randomised placebo-controlled trial (the LEARNS study) 2019 ·BMJ Open ·Floor Veltkamp, (unknown), (unknown), (unknown), Hedy A. van Oers, Elena Levtchenko, Ron A. A. Mathôt, Sandrine Florquin, J. A. E. van Wijk, Michiel F. Schreuder, Lotte Haverman, Antonia H. Bouts	14
19	Dutch norms for the Strengths and Difficulties Questionnaire (SDQ) – parent form for children aged 2–18 years 2018 ·Health and Quality of Life Outcomes ·Heleen Maurice‐Stam, Lotte Haverman, (unknown), Hedy A. van Oers, Sasja A. Schepers, Martha A. Grootenhuis	63
20	Health related quality of life and parental perceptions of child vulnerability among parents of a child with juvenile idiopathic arthritis: results from a web-based survey 2014 ·Pediatric Rheumatology ·Lotte Haverman, Hedy A. van Oers, Heleen Maurice‐Stam, Taco W. Kuijpers, Martha A. Grootenhuis, Marion A. van Rossum	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact